 | • レポートコード：QYR9ST00779 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の抗血栓薬市場について調査・分析し、以下の構成でお届け致します。抗血栓薬の種類別には、アピキサバン、デビガトラン、エドキサバン、フォンダパリヌックス、ヘパリン、リバロキサバンに、用途別には、一般薬局、病院薬局、オンライン小売業者、ドラッグストアに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別抗血栓薬売上データ ・地域別抗血栓薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別抗血栓薬市場規模：アピキサバン、デビガトラン、エドキサバン、フォンダパリヌックス、ヘパリン、リバロキサバン ・用途別抗血栓薬市場規模：一般薬局、病院薬局、オンライン小売業者、ドラッグストア ・主要メーカーの企業情報：Bristol myers squibb pharma、Abbott laboratories、Pliva、Sandoz、Pfizer、Pharmacia、Watson laboratories、Zydus pharmaceuticals usa、Bristol-Myers Squibb ・抗血栓薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Thrombosis is may be defined as the formation of blood clot in the blood vessel or lumen part of the blood vessel. Formation of blood clots inside the blood vessel causes disruption of blood flow and it leads to cause death of cells. Deep vein thrombosis (DVT) is one type of thrombosis and it affects larger muscle of thigh. As a result, it causes pain, swelling in the leg and also it causes pulmonary embolism. Deep vein thrombosis (DVT) and pulmonary embolism collectively called as venous thromboembolism (VTE). Deep vein thrombosis is usually affects legs, sometimes it also affects chest, arm and other parts of body. If it happens in brain, lungs and heart then that could cause damage of organ. Increasing prevalence of cardiac related and cancer diseases is one of the factor which is expected to drive the overall anti thrombotic drugs. The significant growth in a market over a forecast period is mainly attributed by increasing hereditary diseases. Globally, increasing hypertension also expected to drive the market over the forecast period. Increasing awareness about life-threatening diseases among people is a key factor and that is expected to fuel the sales of overall anti thrombotic drugs during 2016-2024. Availability of branded drugs along with generics is expected to increase the market revenue. Changing lifestyles and lack of physical activity is one of the factor which affects the growth of the market moderately during the forecast period.
The global Antithrombotic Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antithrombotic Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Antithrombotic Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antithrombotic Drugs in these regions.
This research report categorizes the global Antithrombotic Drugs market by top players/brands, region, type and end user. This report also studies the global Antithrombotic Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bristol myers squibb pharma
Abbott laboratories
Pliva
Sandoz
Pfizer
Pharmacia
Watson laboratories
Zydus pharmaceuticals usa
Bristol-Myers Squibb
Market size by Product
Apixaban
Debigatran
Edoxaban
Fondaparinux
Heparin
Rivaroxaban
Market size by End User
General Pharmacies
Hospital Pharmacies
Online Retailers
Drug Stores
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Antithrombotic Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antithrombotic Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antithrombotic Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antithrombotic Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antithrombotic Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antithrombotic Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Antithrombotic Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antithrombotic Drugs Market Size Growth Rate by Product
1.4.2 Apixaban
1.4.3 Debigatran
1.4.4 Edoxaban
1.4.5 Fondaparinux
1.4.6 Heparin
1.4.7 Rivaroxaban
1.5 Market by End User
1.5.1 Global Antithrombotic Drugs Market Size Growth Rate by End User
1.5.2 General Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Online Retailers
1.5.5 Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antithrombotic Drugs Market Size
2.1.1 Global Antithrombotic Drugs Revenue 2014-2025
2.1.2 Global Antithrombotic Drugs Sales 2014-2025
2.2 Antithrombotic Drugs Growth Rate by Regions
2.2.1 Global Antithrombotic Drugs Sales by Regions
2.2.2 Global Antithrombotic Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Antithrombotic Drugs Sales by Manufacturers
3.1.1 Antithrombotic Drugs Sales by Manufacturers
3.1.2 Antithrombotic Drugs Sales Market Share by Manufacturers
3.1.3 Global Antithrombotic Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Antithrombotic Drugs Revenue by Manufacturers
3.2.1 Antithrombotic Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Antithrombotic Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Antithrombotic Drugs Price by Manufacturers
3.4 Antithrombotic Drugs Manufacturing Base Distribution, Product Types
3.4.1 Antithrombotic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antithrombotic Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Antithrombotic Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Antithrombotic Drugs Sales by Product
4.2 Global Antithrombotic Drugs Revenue by Product
4.3 Antithrombotic Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Antithrombotic Drugs Breakdown Data by End User
6 North America
6.1 North America Antithrombotic Drugs by Countries
6.1.1 North America Antithrombotic Drugs Sales by Countries
6.1.2 North America Antithrombotic Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Antithrombotic Drugs by Product
6.3 North America Antithrombotic Drugs by End User
7 Europe
7.1 Europe Antithrombotic Drugs by Countries
7.1.1 Europe Antithrombotic Drugs Sales by Countries
7.1.2 Europe Antithrombotic Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antithrombotic Drugs by Product
7.3 Europe Antithrombotic Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Antithrombotic Drugs by Countries
8.1.1 Asia Pacific Antithrombotic Drugs Sales by Countries
8.1.2 Asia Pacific Antithrombotic Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Antithrombotic Drugs by Product
8.3 Asia Pacific Antithrombotic Drugs by End User
9 Central & South America
9.1 Central & South America Antithrombotic Drugs by Countries
9.1.1 Central & South America Antithrombotic Drugs Sales by Countries
9.1.2 Central & South America Antithrombotic Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Antithrombotic Drugs by Product
9.3 Central & South America Antithrombotic Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Antithrombotic Drugs by Countries
10.1.1 Middle East and Africa Antithrombotic Drugs Sales by Countries
10.1.2 Middle East and Africa Antithrombotic Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Antithrombotic Drugs by Product
10.3 Middle East and Africa Antithrombotic Drugs by End User
11 Company Profiles
11.1 Bristol myers squibb pharma
11.1.1 Bristol myers squibb pharma Company Details
11.1.2 Company Business Overview
11.1.3 Bristol myers squibb pharma Antithrombotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Bristol myers squibb pharma Antithrombotic Drugs Products Offered
11.1.5 Bristol myers squibb pharma Recent Development
11.2 Abbott laboratories
11.2.1 Abbott laboratories Company Details
11.2.2 Company Business Overview
11.2.3 Abbott laboratories Antithrombotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Abbott laboratories Antithrombotic Drugs Products Offered
11.2.5 Abbott laboratories Recent Development
11.3 Pliva
11.3.1 Pliva Company Details
11.3.2 Company Business Overview
11.3.3 Pliva Antithrombotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Pliva Antithrombotic Drugs Products Offered
11.3.5 Pliva Recent Development
11.4 Sandoz
11.4.1 Sandoz Company Details
11.4.2 Company Business Overview
11.4.3 Sandoz Antithrombotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sandoz Antithrombotic Drugs Products Offered
11.4.5 Sandoz Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Business Overview
11.5.3 Pfizer Antithrombotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Pfizer Antithrombotic Drugs Products Offered
11.5.5 Pfizer Recent Development
11.6 Pharmacia
11.6.1 Pharmacia Company Details
11.6.2 Company Business Overview
11.6.3 Pharmacia Antithrombotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Pharmacia Antithrombotic Drugs Products Offered
11.6.5 Pharmacia Recent Development
11.7 Watson laboratories
11.7.1 Watson laboratories Company Details
11.7.2 Company Business Overview
11.7.3 Watson laboratories Antithrombotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Watson laboratories Antithrombotic Drugs Products Offered
11.7.5 Watson laboratories Recent Development
11.8 Zydus pharmaceuticals usa
11.8.1 Zydus pharmaceuticals usa Company Details
11.8.2 Company Business Overview
11.8.3 Zydus pharmaceuticals usa Antithrombotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Zydus pharmaceuticals usa Antithrombotic Drugs Products Offered
11.8.5 Zydus pharmaceuticals usa Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Company Business Overview
11.9.3 Bristol-Myers Squibb Antithrombotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Bristol-Myers Squibb Antithrombotic Drugs Products Offered
11.9.5 Bristol-Myers Squibb Recent Development
12 Future Forecast
12.1 Antithrombotic Drugs Market Forecast by Regions
12.1.1 Global Antithrombotic Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Antithrombotic Drugs Revenue Forecast by Regions 2019-2025
12.2 Antithrombotic Drugs Market Forecast by Product
12.2.1 Global Antithrombotic Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Antithrombotic Drugs Revenue Forecast by Product 2019-2025
12.3 Antithrombotic Drugs Market Forecast by End User
12.4 North America Antithrombotic Drugs Forecast
12.5 Europe Antithrombotic Drugs Forecast
12.6 Asia Pacific Antithrombotic Drugs Forecast
12.7 Central & South America Antithrombotic Drugs Forecast
12.8 Middle East and Africa Antithrombotic Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antithrombotic Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Antithrombotic Drugs Product Picture
Table Antithrombotic Drugs Market Segments
Table Key Manufacturers Antithrombotic Drugs Covered
Table Global Antithrombotic Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Antithrombotic Drugs Sales Market Share by Product 2014-2025
Figure Apixaban Product Picture
Table Major Manufacturers of Apixaban
Figure Debigatran Product Picture
Table Major Manufacturers of Debigatran
Figure Edoxaban Product Picture
Table Major Manufacturers of Edoxaban
Figure Fondaparinux Product Picture
Table Major Manufacturers of Fondaparinux
Figure Heparin Product Picture
Table Major Manufacturers of Heparin
Figure Rivaroxaban Product Picture
Table Major Manufacturers of Rivaroxaban
Table Global Antithrombotic Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure General Pharmacies
Figure Hospital Pharmacies
Figure Online Retailers
Figure Drug Stores
Figure Antithrombotic Drugs Report Years Considered
Figure Global Antithrombotic Drugs Market Size 2014-2025 (Million US$)
Figure Global Antithrombotic Drugs Sales 2014-2025 (K Units)
Table Global Antithrombotic Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Antithrombotic Drugs Sales by Regions 2014-2019 (K Units)
Table Global Antithrombotic Drugs Sales Market Share by Regions 2014-2019
Figure Global Antithrombotic Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Antithrombotic Drugs Sales Market Share by Regions
Table Global Antithrombotic Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Antithrombotic Drugs Revenue Market Share by Regions 2014-2019
Figure Global Antithrombotic Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Antithrombotic Drugs Revenue Market Share by Regions
Table Global Antithrombotic Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Antithrombotic Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Antithrombotic Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Antithrombotic Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Antithrombotic Drugs Revenue Share by Manufacturers (2014-2019)
Figure Antithrombotic Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Antithrombotic Drugs Price (2014-2019) (USD/Unit)
Table Antithrombotic Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Antithrombotic Drugs Product Type
Table Date of International Manufacturers Enter into Antithrombotic Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Antithrombotic Drugs Sales by Product (2014-2019) (K Units)
Table Global Antithrombotic Drugs Sales Share by Product (2014-2019)
Figure Global Antithrombotic Drugs Sales Market Share by Product (2014-2019)
Figure Global Antithrombotic Drugs Sales Market Share by Product in 2018
Table Global Antithrombotic Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Antithrombotic Drugs Revenue Share by Product (2014-2019)
Figure Global Antithrombotic Drugs Revenue Market Share by Product (2014-2019)
Figure Global Antithrombotic Drugs Revenue Market Share by Product in 2018
Table Antithrombotic Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Antithrombotic Drugs Sales by End User (2014-2019) (K Units)
Table Global Antithrombotic Drugs Sales Share by End User (2014-2019)
Figure Global Sales Antithrombotic Drugs Market Share by End User (2014-2019)
Figure Global Sales Antithrombotic Drugs Market Share by End User in 2018
Figure North America Antithrombotic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Antithrombotic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Antithrombotic Drugs Sales by Countries (2014-2019) (K Units)
Table North America Antithrombotic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Antithrombotic Drugs Sales Market Share by Countries
Table North America Antithrombotic Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Antithrombotic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Antithrombotic Drugs Revenue Market Share by Countries
Figure United States Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Antithrombotic Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Antithrombotic Drugs Sales by Product (2014-2019) (K Units)
Table North America Antithrombotic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Antithrombotic Drugs Market Share by Product
Table North America Antithrombotic Drugs Sales by End User (2014-2019) (K Units)
Table North America Antithrombotic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Antithrombotic Drugs Market Share by End User
Figure Europe Antithrombotic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Antithrombotic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Antithrombotic Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Antithrombotic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Antithrombotic Drugs Sales Market Share by Countries
Table Europe Antithrombotic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Antithrombotic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Antithrombotic Drugs Revenue Market Share by Countries
Figure Germany Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Antithrombotic Drugs Sales by Product (2014-2019) (K Units)
Table Europe Antithrombotic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Antithrombotic Drugs Market Share by Product
Table Europe Antithrombotic Drugs Sales by End User (2014-2019) (K Units)
Table Europe Antithrombotic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Antithrombotic Drugs Market Share by End User
Figure Asia Pacific Antithrombotic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Antithrombotic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Antithrombotic Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Antithrombotic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antithrombotic Drugs Sales Market Share by Countries
Table Asia Pacific Antithrombotic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Antithrombotic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antithrombotic Drugs Revenue Market Share by Countries
Figure China Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Antithrombotic Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Antithrombotic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Antithrombotic Drugs Market Share by Product
Table Asia Pacific Antithrombotic Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Antithrombotic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Antithrombotic Drugs Market Share by End User
Figure Central & South America Antithrombotic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Antithrombotic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Antithrombotic Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Antithrombotic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antithrombotic Drugs Sales Market Share by Countries
Table Central & South America Antithrombotic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Antithrombotic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antithrombotic Drugs Revenue Market Share by Countries
Figure Brazil Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Antithrombotic Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Antithrombotic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Antithrombotic Drugs Market Share by Product
Table Central & South America Antithrombotic Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Antithrombotic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Antithrombotic Drugs Market Share by End User
Figure Middle East and Africa Antithrombotic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Antithrombotic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Antithrombotic Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Antithrombotic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antithrombotic Drugs Sales Market Share by Countries
Table Middle East and Africa Antithrombotic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Antithrombotic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antithrombotic Drugs Revenue Market Share by Countries
Figure GCC Countries Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Antithrombotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Antithrombotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Antithrombotic Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Antithrombotic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Antithrombotic Drugs Market Share by Product
Table Middle East and Africa Antithrombotic Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Antithrombotic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Antithrombotic Drugs Market Share by End User
Table Bristol myers squibb pharma Company Details
Table Bristol myers squibb pharma Antithrombotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol myers squibb pharma Recent Development
Table Abbott laboratories Company Details
Table Abbott laboratories Antithrombotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott laboratories Recent Development
Table Pliva Company Details
Table Pliva Antithrombotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pliva Recent Development
Table Sandoz Company Details
Table Sandoz Antithrombotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sandoz Recent Development
Table Pfizer Company Details
Table Pfizer Antithrombotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Pharmacia Company Details
Table Pharmacia Antithrombotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pharmacia Recent Development
Table Watson laboratories Company Details
Table Watson laboratories Antithrombotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Watson laboratories Recent Development
Table Zydus pharmaceuticals usa Company Details
Table Zydus pharmaceuticals usa Antithrombotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Zydus pharmaceuticals usa Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Antithrombotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Global Antithrombotic Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Antithrombotic Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Antithrombotic Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Antithrombotic Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Antithrombotic Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Antithrombotic Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Antithrombotic Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Antithrombotic Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Antithrombotic Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Antithrombotic Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Antithrombotic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Antithrombotic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Antithrombotic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Antithrombotic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Antithrombotic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Antithrombotic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Antithrombotic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Antithrombotic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Antithrombotic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Antithrombotic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Antithrombotic Drugs Value Chain
Table Antithrombotic Drugs Customers List
Table Antithrombotic Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
虚血性心疾患（IHD）医薬品の世界市場：インサイト・予測 Ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. It is within the group of cardiovascular diseases of which it is the most common type. A common symptom is chest pain or discomfort which may tr…- HIV薬の世界市場：インサイト・予測 HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population.One …
- タイサブリ薬の世界市場：インサイト・予測 Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried without successful treatment of this con…
- 抗自殺薬の世界市場：インサイト・予測 Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for p…
- 認知症薬の世界市場：インサイト・予測 The global Dementia Drugs market is valued at 13900 million US$ in 2018 and will reach 26500 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dementia Drugs market based on company, product ty…